 |
Prospector
Profile
117-01
|
| |
| In Veritas Medical Diagnostics, Inc. |
NAICS |
334510 |
| The Green House, Beechwood BusinessPark North
Inverness, Scotland IV2 3BL |
Description |
Medical Device Mfg. |
| 011 44-1463-667-347 |
Employees |
0 |
| http://ivmd.com/ |
Revenue |
(mil) |
0.0000 |
| |
Income |
(mil) |
-3.6700 |
| |
Assets |
(mil) |
0.1119 |
| |
Liability |
(mil) |
7.1190 |
| |
(for the year ended 2007-07-31) |
| |
|
Category:
Loss/Deficit
|
| |
|
Event:
In Veritas Diagnostics, Inc., had a net loss of $656,025 for the first quarter ended October 31, 2007, slightly lower than the $866,396 net loss incurred during the first quarter of 2006. The Company’s balance sheet at October 31, 2007, showed an accumulated deficit of $13,082,158 and stockholders' deficit of $7,598,303. It also has strained liquidity with $16,937 in total current assets available to pay $7,031,174 in total current liabilities.
|
| |
|
Intellectual Property:
The Company has applied for 13 patents, 3 of which have been granted. It is currently working on a number of additional patent applications in related areas. The first product to be completed using its technology is a prothrombin measurement device, which is used for the measurement of coagulation of blood in patients at risk of heart disease and stroke. The Company is developing additional hand held or portable products which are focused on the measurement and detection of pregnancy and labor and the detection of diseases and medical conditions using magnetic detection techniques applied to tissue and blood. [SEC Filing 10-KSB 11-13-2007]
|
| |
|
Description:
In Veritas Medical Diagnostics, Inc., specializes in the field of near patient medical diagnostics, also known as "point of care".
|
| |
|
Officers:
Graham Cooper (Chair., Pres. & CEO); Martin Thorp (CFO)
|
| |
|
Auditor:
Cordovano and Honeck LLP
|
| |
|
Securities:
Common Stock-Symbol IVME.OB; OTC BB;
86,103,457common shares outstanding as of December 14, 2007.
|
| |
| |
| |
| return to main page |
|
|
